45 related articles for article (PubMed ID: 21601006)
1. Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells.
Liao YX; Zeng JM; Zhou JJ; Yang GH; Ding K; Zhang XJ
Mol Med Rep; 2016 Jun; 13(6):4872-8. PubMed ID: 27082503
[TBL] [Abstract][Full Text] [Related]
2. Biochemical, proteomic, structural, and thermodynamic characterizations of integrin-linked kinase (ILK): cross-validation of the pseudokinase.
Fukuda K; Knight JD; Piszczek G; Kothary R; Qin J
J Biol Chem; 2011 Jun; 286(24):21886-95. PubMed ID: 21524996
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the ILK-AKT pathway by upregulation of PARVB contributes to the cochlear cell death in Fascin2 gene knockout mice.
Liu R; Shang W; Liu Y; Xie Y; Luan J; Zhang T; Ma Y; Wang Z; Sun Y; Song X; Han F
Cell Death Discov; 2024 Feb; 10(1):89. PubMed ID: 38374196
[TBL] [Abstract][Full Text] [Related]
4. Integrin-linked kinase (ILK): the known vs. the unknown and perspectives.
Górska A; Mazur AJ
Cell Mol Life Sci; 2022 Jan; 79(2):100. PubMed ID: 35089438
[TBL] [Abstract][Full Text] [Related]
5. Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer.
Zheng CC; Hu HF; Hong P; Zhang QH; Xu WW; He QY; Li B
Am J Cancer Res; 2019; 9(1):186-197. PubMed ID: 30755822
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma.
Lv M; Zhong Z; Chi H; Huang M; Jiang R; Chen J
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28042869
[TBL] [Abstract][Full Text] [Related]
7. Integrin-linked kinase regulates cadherin switch in bladder cancer.
Gil D; Ciołczyk-Wierzbicka D; Dulińska-Litewka J; Laidler P
Tumour Biol; 2016 Nov; 37(11):15185-15191. PubMed ID: 27683053
[TBL] [Abstract][Full Text] [Related]
8. Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.
Zhuang X; Lv M; Zhong Z; Zhang L; Jiang R; Chen J
J Exp Clin Cancer Res; 2016 Aug; 35(1):130. PubMed ID: 27576342
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapies in bladder cancer: an overview of in vivo research.
van Kessel KE; Zuiverloon TC; Alberts AR; Boormans JL; Zwarthoff EC
Nat Rev Urol; 2015 Dec; 12(12):681-94. PubMed ID: 26390971
[TBL] [Abstract][Full Text] [Related]
10. RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis.
Zhao X; Xu Z; Wang Z; Wu Z; Gong Y; Zhou L; Xiang Y
Mol Med Rep; 2015 Jul; 12(1):960-6. PubMed ID: 25760437
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-κB pathway.
Liang F; Zhang S; Wang B; Qiu J; Wang Y
J Mol Histol; 2014 Apr; 45(2):141-51. PubMed ID: 24045896
[TBL] [Abstract][Full Text] [Related]
12. Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells.
Zhang HJ; Yao DF; Yao M; Huang H; Wang L; Yan MJ; Yan XD; Gu X; Wu W; Lu SL
World J Gastroenterol; 2013 Jun; 19(24):3792-801. PubMed ID: 23840117
[TBL] [Abstract][Full Text] [Related]
13. Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway.
Li L; Pan XY; Shu J; Jiang R; Zhou YJ; Chen JX
Biochimie; 2014 Aug; 103():89-100. PubMed ID: 24769129
[TBL] [Abstract][Full Text] [Related]
14. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
15. Targeting of integrin-linked kinase with a small interfering RNA inhibits endothelial cell migration, proliferation and tube formation in vitro.
Guo L; Yu W; Li X; Zhao G; He P
Ophthalmic Res; 2009; 42(4):213-20. PubMed ID: 19672130
[TBL] [Abstract][Full Text] [Related]
16. Integrin-linked kinase: not so 'pseudo' after all.
Hannigan GE; McDonald PC; Walsh MP; Dedhar S
Oncogene; 2011 Oct; 30(43):4375-85. PubMed ID: 21602880
[TBL] [Abstract][Full Text] [Related]
17. Integrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties.
Yoganathan N; Yee A; Zhang Z; Leung D; Yan J; Fazli L; Kojic DL; Costello PC; Jabali M; Dedhar S; Sanghera J
Pharmacol Ther; 2002; 93(2-3):233-42. PubMed ID: 12191615
[TBL] [Abstract][Full Text] [Related]
18. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX
Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
